1.
Effectiveness and persistence of Vedolizumab in patients with inflammatory bowel disease : results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE).
2.
3.
4.
5.
6.
7.
8.
9.
Hepatitis B virus and hepatitis C virus infection in Belgium: similarities and differences in epidemic and initial management